JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
Scope & Guideline
Leading the charge in molecular and cellular cardiology research.
Introduction
Aims and Scopes
- Molecular Mechanisms in Cardiac Function:
Research on the molecular pathways that regulate cardiac function, including signaling cascades, gene expression, and metabolic processes that influence heart health. - Cardiovascular Disease Mechanisms:
Studies exploring the pathophysiology of various cardiovascular diseases such as heart failure, arrhythmias, and cardiomyopathies, emphasizing the cellular and molecular alterations involved. - Innovative Therapeutic Strategies:
Development and evaluation of novel therapeutic approaches, including gene therapy, stem cell therapy, and pharmacological interventions aimed at repairing or regenerating cardiac tissue. - Cardiac Regeneration and Repair:
Research focused on the mechanisms underlying cardiac regeneration, including the role of stem cells, extracellular matrix, and signaling pathways in promoting tissue repair. - Sex Differences in Cardiovascular Health:
Investigation of how biological sex influences cardiovascular health, disease prevalence, and treatment response, with a focus on molecular and cellular differences. - Integrative Omics Approaches:
Utilization of multi-omics technologies (genomics, proteomics, metabolomics) to provide comprehensive insights into cardiovascular biology and disease mechanisms.
Trending and Emerging
- Cardiovascular Metabolism:
An increasing focus on the role of metabolic pathways in cardiac health and disease, particularly how metabolic dysregulation contributes to conditions such as obesity, diabetes, and heart failure. - Gene Editing and Gene Therapy:
A surge in research utilizing CRISPR and other gene editing technologies to explore genetic underpinnings of cardiovascular diseases and develop targeted gene therapies. - Extracellular Vesicles and Cell Communication:
Emerging studies investigating the role of extracellular vesicles in intercellular communication and their potential as biomarkers or therapeutic agents in cardiovascular diseases. - Inflammation and Immunology in Cardiology:
Growing interest in understanding the immune response in cardiovascular diseases, particularly how inflammation contributes to disease progression and the potential for immunomodulatory therapies. - Single-Cell and Multi-Omics Approaches:
The adoption of single-cell sequencing and integrative multi-omics approaches is on the rise, allowing for a more detailed understanding of cellular heterogeneity and the molecular landscape of cardiovascular diseases. - Personalized Medicine and Cardiovascular Health:
A trend towards personalized approaches to cardiovascular disease management, incorporating genetic, molecular, and clinical data to tailor treatments to individual patients.
Declining or Waning
- Traditional Pharmacology:
There is a noticeable reduction in studies centered on traditional pharmacological approaches to treating heart disease, as the field shifts towards more innovative and targeted therapeutic strategies. - Basic Animal Models:
Research using basic animal models without advanced genetic manipulations or disease modeling techniques has decreased, reflecting a broader trend towards more sophisticated and translational modeling approaches. - Cardiac Imaging Techniques:
While imaging remains a crucial tool in cardiology, there is less emphasis on traditional imaging studies (e.g., echocardiography) in favor of molecular and cellular investigations that provide deeper mechanistic insights. - Aging Research in Cardiovascular Disease:
Although aging is a critical factor in cardiovascular health, publications specifically addressing aging-related mechanisms in a standalone manner have diminished, likely due to a shift towards integrated approaches that consider aging as a variable within broader studies.
Similar Journals
ACTA CARDIOLOGICA
Elevating standards in cardiovascular health research.ACTA CARDIOLOGICA is a distinguished journal published by TAYLOR & FRANCIS LTD, focusing on the dynamic fields of Cardiology and Cardiovascular Medicine. Established in 1946, the journal has maintained a significant presence in the academic community, providing a platform for cutting-edge research and clinical studies that aim to address challenges in cardiovascular health. With its Q3 rating in both Cardiology and General Medicine categories, it showcases a robust compilation of articles that reflect the evolving landscape of cardiac care. Although ACTA CARDIOLOGICA is not an Open Access journal, it continues to serve a vital role for researchers, professionals, and students dedicated to advancing knowledge in cardiovascular health. This journal, with an ISSN of 0001-5385 and E-ISSN of 1784-973X, is a critical resource for those looking to stay updated on the latest developments and practices in the specialization, contributing significantly to the field until 2024 and beyond.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
Advancing Knowledge in Cellular ScienceCellular Physiology and Biochemistry is a premier Open Access journal published by the prestigious Cell Physiol Biochem Press GmbH & Co, dedicated to advancing research in the fields of physiology, biochemistry, and molecular biology. Since its inception in 1987 and transitioning to an Open Access model in 2013, the journal has established itself as a vital resource for the dissemination of high-quality research and reviews, showcasing innovative methodologies and groundbreaking findings in cellular processes. With an impressive ranking in the 2023 Scopus category as Q2 in Physiology and a robust percentile of 61, Cellular Physiology and Biochemistry is committed to fostering academic dialogue among researchers, professionals, and students alike. This journal not only provides unrestricted access to its articles, but also promotes the global sharing of knowledge, which is essential for the advancement of our understanding in these vital scientific areas. The journal's editorial team is dedicated to ensuring the highest standards of academic rigor and relevance, making it an indispensable addition to the libraries of those engaged in the life sciences.
CELL RESEARCH
Elevating Insights in Cell and Molecular SciencesCELL RESEARCH is a premier peer-reviewed journal dedicated to advancing the field of cell biology and molecular biology, published by SpringerNature. With an impressive impact factor and consistently ranking in the Q1 quartile for both cell biology and molecular biology, this journal serves as a pivotal resource for researchers, professionals, and students seeking to explore the latest discoveries and advancements in cellular mechanisms and their implications for health and disease. Since its inception in 1996, CELL RESEARCH has cultivated a distinguished reputation, currently boasting ranks in the top percentile of Scopus categories, reaffirming its influence and relevance to the scientific community. Although it is not an Open Access journal, its rigorous selection process ensures the publication of high-quality articles that contribute significantly to our understanding of life sciences. For those deeply engaged in the realms of biochemistry, genetics, and molecular biology, CELL RESEARCH is an essential conduit of innovative research and critical insights.
Revista Portuguesa de Cardiologia
Empowering the fight against heart disease through open access research.Revista Portuguesa de Cardiologia, published by Elsevier España SLU, stands as a pivotal resource in the realm of Cardiology and Cardiovascular Medicine. With its origins tracing back to 1970, this journal has cultivated a robust academic presence, achieving a 2023 Q3 ranking in its category, and currently holding a position of #220 out of 387 on the Scopus rankings, placing it within the 43rd percentile of its field. This open access journal, available since 2011, aims to disseminate high-quality research and insights relevant to contemporary cardiovascular issues. Its commitment to accessibility and knowledge exchange enhances its importance for clinicians, researchers, and students alike, fostering a more informed community in the fight against cardiovascular diseases. Operating from its base in Barcelona, Spain, the journal welcomes contributions that further the understanding and treatment of heart conditions, contributing significantly to the advancement of cardiovascular health.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
Advancing the Frontiers of Biomedical ResearchCanadian Journal of Physiology and Pharmacology, published by Canadian Science Publishing, is a leading peer-reviewed journal dedicated to advancing knowledge in the fields of physiology and pharmacology. With an ISSN of 0008-4212 and an E-ISSN of 1205-7541, this journal has been at the forefront of biomedical research since its inception in 1964. The journal operates within a constrained access model, ensuring a selective dissemination of high-quality research, while maintaining its esteemed position in the Q3 quartile across multiple relevant categories such as Medicine, Pharmacology, and Physiology as of 2023. Researchers, professionals, and students alike will find the journal a valuable resource for emerging trends and comprehensive studies that shape contemporary science, as evidenced by its competitive Scopus rankings. The Canadian Journal of Physiology and Pharmacology is vital for fostering scholarly dialogue and innovation in the scientific community, encouraging contributions that promote a deeper understanding of physiological and pharmacological phenomena.
CIRCULATION RESEARCH
Transforming research into practice for healthier hearts.CIRCULATION RESEARCH is a premier journal dedicated to advancing the field of cardiovascular science, focusing on innovative research in cardiology and physiology. Published by Lippincott Williams & Wilkins, this esteemed journal has been a cornerstone of cardiovascular research since its inception in 1953, maintaining rigorous standards of scholarly excellence. With an impressive impact factor and ranking in the top quartiles for both Cardiology and Cardiovascular Medicine (Q1) and Physiology (Q1), it holds a significant position in the Scopus database. This journal features cutting-edge studies aimed at understanding the mechanisms of cardiovascular health and disease, promoting the translation of research into clinical practice. Weekly issues provide practitioners and researchers alike with vital insights to keep abreast of the latest developments. Although it does not offer open access, CIRCULATION RESEARCH remains vital for professionals striving to enhance their knowledge and impact in the ever-evolving landscape of cardiovascular medicine.
World Journal of Cardiology
Fostering collaboration and discovery in cardiovascular research.World Journal of Cardiology, published by BAISHIDENG PUBLISHING GROUP INC, stands out as a pivotal resource in the field of cardiology and cardiovascular medicine. With an ISSN of 1949-8462, this journal serves a global audience, promoting knowledge dissemination and collaboration among researchers, healthcare professionals, and students dedicated to advancing cardiovascular health. The journal demonstrates its credibility and impact in the field by achieving a respectable Q2 ranking in the 2023 category of Cardiology and Cardiovascular Medicine. Notably, it is listed in the Scopus database, ranking #189 out of 387 journals, placing it in the 51st percentile, which underscores its relevance and contribution to contemporary cardiovascular research. Although it operates under a subscription model, the journal provides diverse access options, ensuring that critical findings reach a wide audience. Through its comprehensive scope and commitment to publishing high-quality articles, the World Journal of Cardiology plays a vital role in shaping the future of cardiovascular science, making it an invaluable asset for those involved in this essential discipline.
CELLULAR SIGNALLING
Connecting Discoveries in Molecular BiologyCELLULAR SIGNALLING, published by Elsevier Science Inc, is a premier journal within the realm of Cell Biology, boasting an impressive Q2 category ranking as of 2023. With an ISSN of 0898-6568 and an E-ISSN of 1873-3913, the journal has established itself as a critical platform for advancing the understanding of cellular mechanisms and signal transduction pathways since its inception in 1989. Covering a vast array of topics in Biochemistry, Genetics, and Molecular Biology, it ranks notably at 87 out of 285 in the Scopus list, placing it in the 69th percentile among its peers. The journal serves as an invaluable resource for researchers, professionals, and students seeking high-quality, impactful studies that drive forward the field of cellular biology. While it operates under traditional subscription access, its highlights include rigorous peer-reviewed articles, reviews, and insights that continue to shape current scientific discourse.
npj Regenerative Medicine
Shaping the Future of Therapeutic Advancements.npj Regenerative Medicine, published by NATURE PORTFOLIO, is at the forefront of research and innovation in the field of regenerative medicine, fostering a deep understanding of cellular and molecular processes that can be leveraged for therapeutic advancements. Launched as an Open Access journal since 2016, it ensures wide dissemination of knowledge, allowing researchers, professionals, and students to access high-quality articles without barriers. With an impressive impact, it holds Q1 ratings across multiple categories including Biomedical Engineering, Cell Biology, Developmental Biology, and Medicine (miscellaneous) as of 2023, indicating its critical role in shaping contemporary scientific discourse. The journal ranks notably within the top 10% in multiple Scopus categories, indicating its commitment to publishing pioneering research that addresses pressing challenges in regenerative therapies. Addressing the dynamic convergence of disciplines, npj Regenerative Medicine is poised to not only impact academic thought but also translate into clinical applications, making it a pivotal resource for those invested in the future of medicine.
Nature Cardiovascular Research
Advancing cardiovascular knowledge for a healthier tomorrow.Nature Cardiovascular Research, published by SpringerNature in Germany, stands as a premier journal dedicated to advancing the field of cardiovascular sciences. With an impressive 2023 categorization in the Q1 quartile across multiple disciplines—including Biochemistry, Genetics and Molecular Biology, Cardiology, and Medicine—this journal uniquely positions itself as a leading resource for pioneering research and innovative findings. Although currently not open access, it provides a rich repository of peer-reviewed articles that contribute directly to the evolving landscape of cardiovascular medicine. The journal aims to bridge the knowledge gap between basic science and clinical application, catering to researchers, healthcare professionals, and students alike who are immersed in the complexities of cardiovascular health. With robust Scopus rankings in key categories, Nature Cardiovascular Research is poised to shape future directions in the field, helping to foster a deeper understanding of cardiovascular diseases and their underlying mechanisms. Explore the latest research and be part of the conversation in one of the most impactful scientific domains.